Neurones (FR:NRO)
:NRO
Want to see FR:NRO full AI Analyst Report?
Total Valuation
Neurones has a market cap or net worth of €956.12M. The enterprise value is €646.90M.
Market Cap€956.12M
Enterprise Value€646.90M
Share Statistics
Neurones has 24,328,716 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,328,716
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neurones’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.62%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)10.62%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee125.16K
Profits Per Employee7.60K
Employee Count6,849
Asset Turnover1.14
Inventory Turnover1.10K
Valuation Ratios
The current PE Ratio of Neurones is 6.7. Neurones’s PEG ratio is -14.54.
PE Ratio6.7
PS Ratio1.45
PB Ratio3.11
Price to Fair Value3.11
Price to FCF17.69
Price to Operating Cash Flow11.78
PEG Ratio-14.54
Income Statement
In the last 12 months, Neurones had revenue of 857.20M and earned 61.90M in profits. Earnings per share was 2.14.
Revenue857.20M
Gross Profit90.04M
Operating Income72.33M
Pretax Income82.60M
Net Income61.90M
EBITDA90.32M
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 80.77M and capital expenditures -10.44M, giving a free cash flow of 70.33M billion.
Operating Cash Flow80.77M
Free Cash Flow70.33M
Free Cash Flow per Share2.89
Dividends & Yields
Neurones pays an annual dividend of €1.3, resulting in a dividend yield of 3.07%
Dividend Per Share€1.3
Dividend Yield3.07%
Payout Ratio62.20%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change-13.15%
50-Day Moving Average36.21
200-Day Moving Average39.34
Relative Strength Index (RSI)68.20
Average Volume (3m)6.80K
Important Dates
Neurones upcoming earnings date is Sep 9, 2026, TBA (Confirmed).
Last Earnings DateMar 11, 2026
Next Earnings DateSep 9, 2026
Ex-Dividend Date―
Financial Position
Neurones as a current ratio of 2.43, with Debt / Equity ratio of 9.24%
Current Ratio2.43
Quick Ratio2.43
Debt to Market Cap<0.01
Net Debt to EBITDA-3.36
Interest Coverage Ratio60.43
Taxes
In the past 12 months, Neurones has paid 20.75M in taxes.
Income Tax20.75M
Effective Tax Rate0.25
Enterprise Valuation
Neurones EV to EBITDA ratio is 10.41, with an EV/FCF ratio of 13.37.
EV to Sales1.10
EV to EBITDA10.41
EV to Free Cash Flow13.37
EV to Operating Cash Flow11.64
Balance Sheet
Neurones has €340.78M in cash and marketable securities with €36.96M in debt, giving a net cash position of €303.82M billion.
Cash & Marketable Securities€340.78M
Total Debt€36.96M
Net Cash€303.82M
Net Cash Per Share€12.49
Tangible Book Value Per Share€13.91
Margins
Gross margin is 55.35%, with operating margin of 8.44%, and net profit margin of 7.22%.
Gross Margin55.35%
Operating Margin8.44%
Pretax Margin9.64%
Net Profit Margin7.22%
EBITDA Margin10.54%
EBIT Margin8.44%
Analyst Forecast
The average price target for Neurones is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.78%
EPS Growth Forecast-1.04%